Prothena’s clinical stage antibody PRX004 and broader ATTR amyloidosis programme Transaction
Fixed Income Investment Deal in United Kingdom, Europe
Transaction Details
| Name: | Prothena’s clinical stage antibody PRX004 and broader ATTR amyloidosis programme |
| Amount: | Available on swfi.com |
| Announced At: | 07/12/2021 |
| Closed At: | 07/12/2021 |
| Region | Europe |
| Country: | United Kingdom |
| Type: | Deal |
| Security Type: | Royalty |
| Investment Type: | Fixed Income |
| Sector | Healthcare |
| Industry: | Pharmaceuticals |
| Summary: | Available |
Buyers
| Entity 1 Pharmaceutical Company in Denmark | Stake Available on swfi.com |
Sellers
| Entity 1 Company in Ireland | Stake Available on swfi.com |